Hojgaard uses Ryder Cup experience to lead World Tour Championship. McIlroy and Rahm falter late
Nicolai Hojgaard used his Ryder Cup debut to learn off the best golfers in the world and now he’s upstaging them
2023-11-16 22:22
Here's why heavy rain in Florida has little to do with hurricane season
A storm system that formed over the Florida Keys and dumped up to 9 inches of rain across parts of South Florida has moved into the Atlantic Ocean
2023-11-16 22:21
Leonardo focuses on European alliances as it trims DRS stake in US
By Giulia Segreti and Alvise Armellini ROME Italy's Leonardo is trimming its stake in U.S. unit DRS as
2023-11-16 22:21
Oak Row Equities and LNDMRK Development Unveil 2900 Terrace in Edgewater, Miami
MIAMI--(BUSINESS WIRE)--Nov 16, 2023--
2023-11-16 22:19
Spain’s Sanchez Wins New Term Thanks to Catalan Amnesty Deal
Pedro Sanchez won reelection as Spain’s prime minister in a confidence vote in parliament on Thursday with the
2023-11-16 22:18
After court defeat, the UK says its Rwanda migrant plan can still work. Legal experts are skeptical
Britain’s interior minister says the U.K. government can revive its blocked plan to send asylum-seekers to Rwanda without breaching international law
2023-11-16 22:17
Durabook Announces Windows 11 Secured-core PCs in its Mobile Rugged Computing Portfolio
FREMONT, Calif.--(BUSINESS WIRE)--Nov 16, 2023--
2023-11-16 22:16
Cross-border police operation aims to tackle rise in road deaths
There's been a rise in the number of fatal crashes on both sides of the border compared to 2022.
2023-11-16 22:16
Poland’s Sudden Surge in Home Prices Is a Risk, Builder Warns
Poland’s home market risks more volatility after a government program to subsidize mortgages triggered an abrupt surge in
2023-11-16 21:59
U.S. applications for jobless claims rise in a labor market that remains very healthy
More Americans filed for jobless claims last week, but the labor market remains broadly healthy in the face of retreating inflation and elevated interest rates
2023-11-16 21:58
Gene therapy for sickle cell and thalassemia gets approval in the UK, a world first
Britain’s medicines regulator has authorized the world’s first gene therapy treatment for sickle cell disease, in a move that could offer relief to thousands of people with the crippling illness in the U.K. In a statement on Thursday, the Medicines and Healthcare Regulatory Agency said it had approved Casgevy, the first medicine licensed using the gene editing tool CRISPR, which won its makers a Nobel prize in 2020
2023-11-16 21:57
US weekly jobless claims rise more than expected
WASHINGTON The number of Americans filing new claims for unemployment benefits increased more than expected last week, suggesting
2023-11-16 21:56